0001209191-15-069655.txt : 20150904 0001209191-15-069655.hdr.sgml : 20150904 20150904161619 ACCESSION NUMBER: 0001209191-15-069655 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150902 FILED AS OF DATE: 20150904 DATE AS OF CHANGE: 20150904 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-742-3400 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bertolino Arthur Peter CENTRAL INDEX KEY: 0001426344 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 151094773 MAIL ADDRESS: STREET 1: 6475 CHRISTIE AVENUE SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-09-02 0 0001479290 Revance Therapeutics, Inc. RVNC 0001426344 Bertolino Arthur Peter C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560 0 1 0 0 EVP and Chief Medical Officer Common Stock 2015-09-02 4 F 0 3699 30.48 D 41754 D Represents the number of shares withheld by and surrendered to the Issuer on September 2, 2015, to satisfy tax withholding obligations that arose in connection with the vesting of the Restricted Stock Award ("RSA") for 9,844 shares. The RSA vests in four equal annual installments from September 2, 2014, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Inducement Plan) on each vesting date. /s/ Gordon Ho, Attorney-in-fact 2015-09-04